Computational Analysis of Single-Cell Transcriptome Data

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "RNA".

Deadline for manuscript submissions: closed (25 August 2023) | Viewed by 1856

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands
Interests: single-cell RNA sequencing; cancer drug resistance; cell cycle; cell fate analysis; transcription networks; DNA replication stress; bladder cancer; stemness; bioinformatics

Special Issue Information

Dear Colleagues,

Since it first became widely available to researchers in life sciences around 2016, single-cell RNA-sequencing (scRNA-seq) technology has greatly improved our understanding of individual cell function in healthy and diseased tissues. Since then, there has been an exponential growth in the numbers of cells profiled. Moreover, new technologies, such as spatially resolved single-cell transcriptomics and single-cell (epi)genomics, are rapidly improving. However, proper analysis of large amounts of single-cell data requires efficient and innovative computational and statistical methodology.

Various computational and statistical tools now allow researchers to perform transcription factor network analysis, trajectory inference, and predictions of cell–cell interactions. However, there is still a big need for innovative approaches to address challenges in handling sparsity in scRNA-seq, integration of scRNA-seq datasets across experiments and studies, integration of scRNA-seq with other types of single-cell data, recognition of patterns in spatial single-cell transcriptomic data, and validation and benchmarking of analysis tools.

We welcome the submission of original studies that present and validate innovative tools and methodology for computational analysis of single-cell RNA-seq data, and integration with other data types, such as (single-cell) proteomic, metabolomic, or epigenomic data. In addition, we invite comprehensive literature reviews and perspectives about the rapidly expanding toolbox of single-cell transcriptome analysis tools.

Dr. Bart Westendorp
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • single-cell transcriptomics
  • rare cell populations
  • trajectory inference
  • tumor heterogeneity
  • biomarker discovery
  • multi-omic analysis
  • benchmarking computational methods
  • stem cell biology

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

20 pages, 21419 KiB  
Article
Comparison of Single Cell Transcriptome Sequencing Methods: Of Mice and Men
by Bastian V. H. Hornung, Zakia Azmani, Alexander T. den Dekker, Edwin Oole, Zeliha Ozgur, Rutger W. W. Brouwer, Mirjam C. G. N. van den Hout and Wilfred F. J. van IJcken
Genes 2023, 14(12), 2226; https://0-doi-org.brum.beds.ac.uk/10.3390/genes14122226 - 16 Dec 2023
Viewed by 1560
Abstract
Single cell RNAseq has been a big leap in many areas of biology. Rather than investigating gene expression on a whole organism level, this technology enables scientists to get a detailed look at rare single cells or within their cell population of interest. [...] Read more.
Single cell RNAseq has been a big leap in many areas of biology. Rather than investigating gene expression on a whole organism level, this technology enables scientists to get a detailed look at rare single cells or within their cell population of interest. The field is growing, and many new methods appear each year. We compared methods utilized in our core facility: Smart-seq3, PlexWell, FLASH-seq, VASA-seq, SORT-seq, 10X, Evercode, and HIVE. We characterized the equipment requirements for each method. We evaluated the performances of these methods based on detected features, transcriptome diversity, mitochondrial RNA abundance and multiplets, among others and benchmarked them against bulk RNA sequencing. Here, we show that bulk transcriptome detects more unique transcripts than any single cell method. While most methods are comparable in many regards, FLASH-seq and VASA-seq yielded the best metrics, e.g., in number of features. If no equipment for automation is available or many cells are desired, then HIVE or 10X yield good results. In general, more recently developed methods perform better. This also leads to the conclusion that older methods should be phased out, and that the development of single cell RNAseq methods is still progressing considerably. Full article
(This article belongs to the Special Issue Computational Analysis of Single-Cell Transcriptome Data)
Show Figures

Figure 1

Back to TopTop